重组人IL-36γ,169a.a.
产品名称: 重组人IL-36γ,169a.a.
英文名称: Recombinant Human Interleukin-36 gamma, 169a.a.
产品编号: HZ600331
产品价格: 0
产品产地: 中国/上海
品牌商标: HZbscience
更新时间: 2023-08-17T10:24:20
使用范围: null
- 联系人 : 鲍丽雯
- 地址 : 上海市闵行区闵北路88弄1-30号第22幢AQ136室
- 邮编 : 200612
- 所在区域 : 上海
- 电话 : 139****0749
- 传真 : 021-60345367
- 邮箱 : www.shzbio.net
重组人IL-36γ,169a.a.
附带条件
特技
白细胞介素-36(IL-36)是一种促炎症细胞因子,在多种疾病的病理生理过程中起着重要作用。IL-36α、IL-36β和IL-36γ(原IL-1F6、IL-1F8和IL-1F9)是IL-1受体家族成员IL-1 RRP2(IL-1RL2)和IL-1RACP信号转导的IL-1家族成员。IL-36γ在转染到33-T细胞时分泌,它可以构成与白细胞介素-1α(IL-1A)、β(IL-1B)受体激动剂和白细胞介素-1受体I型(IL-1R1)类似的独立信号系统的一部分。此外,IL-36γ还可以通过孤儿IL-1受体相关蛋白2作为NF-κB激动剂发挥作用。将重组人IL-36γ合成为19 kDa、169氨基酸(A.A.)蛋白,不含信号序列、无前片段和无潜在的N-糖基化位点。人对小鼠,IL-36γ共有53% A.A.的身份。在家族中,IL-36γ与IL-1RA、IL-1β、IL-36RA、IL-36α、IL-37、IL-36β和IL-1F10的同源性约为25%~55%。
附带条件
该材料由Sangon生物技术公司提供,用于研究、实验室或进一步评估目的。不适合人类使用。
附带条件
物理外观无菌过滤白冻干(冻干)粉末。
纯度为95%以上,采用SDS-PAGE和HPLC分析。
来源大肠杆菌。
与标准相比,生物活性完全具有生物活性。特异性活性由功能性ELISA中的结合能力决定。固定化的rHuIL-36γ在1μg/ml时,可将重组人IL-1 RRP2 Fc嵌合体结合在0.15~5μg/ml范围内。
用0.2μm过滤浓缩液在pH 7.4的PBS中进行冻干。
LaAl法测定内毒素低于1 EU /μg的rHuIL-36γ,169A.A.
我们建议在打开之前将这个小瓶简单地离心,以将内容物带到底部。在无菌蒸馏水或含0.1% BSA的水性缓冲液中重组,浓度为0.1-1.0mg/mL。储备溶液应分配到工作等分试样中,并储存在小于20?c.应在适当的缓冲溶液中进一步稀释。
AAA序列MRGTPGDADG GRIPYGQDMCL NQQVWTLQGDQ NVLVAVPRSDS VKPVPATVIIT CKPEPARALQEQG RGDPIL GIQ NPMECLYCEKK VGEQPTLQLK EQKIMDLYGQ
概述
Interleukin-36 (IL-36) is a pro-inflammatory cytokine which plays an important role in the pathophysiology of several diseases. IL-36α, IL-36β, and IL-36γ (formerly IL-1F6, IL-1F8, and IL-1F9) are IL-1 family members that signal through the IL-1 receptor family members IL-1Rrp2 (IL-1RL2) and IL-1RAcP. IL-36γ is secreted when transfected into 293-T cells and it could constitute part of an independent signaling system analogous to interleukin-1 alpha (IL-1A), beta (IL-1B) receptor agonist and interleukin-1 receptor type I (IL-1R1). Furthermore, IL-36γ also can function as an agonist of NF-kappa B activation through the orphan IL-1-receptor-related protein 2. Recombinant human IL-36γ is synthesized as a 19 kDa, 169 amino acid (a.a.) protein that contains no signal sequence, no prosegment and no potential N-linked glycosylation site. Human to mouse, IL-36γ shares 53 % a.a. identity. Within the family, IL-36γ shares about 25 % ~ 55 % a.a. sequence identity with IL-1RA, IL-1β, IL-36RA, IL-36α, IL-37, IL-36β and IL-1F10.
使用说明
This material is offered by Sangon Biotech for research, laboratory or further evaluation purposes. NOT FOR HUMAN USE.
技术规格
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Purity | > 95 % by SDS-PAGE and HPLC analyses. |
Source | Escherichia coli. |
Biological Activity | Fully biologically active when compared to standard. The specific activity is determined by its binding ability in a functional ELISA. Immobilized rHuIL-36γ at 1 μg/mL can bind recombinant human IL-1 Rrp2 Fc Chimera with a range of 0.15-5 μg/mL. |
Formulation | Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4. |
Endotoxin | Less than 1 EU/μg of rHuIL-36γ, 169a.a. as determined by LAL method. |
Reconstitution | We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 ?C. Further dilutions should be made in appropriate buffered solutions. |
AA Sequence | MRGTPGDADG GGRAVYQSMC KPITGTINDL NQQVWTLQGQ NLVAVPRSDS VTPVTVAVIT CKYPEALEQG RGDPIYLGIQ NPEMCLYCEK VGEQPTLQLK EQKIMDLYGQ PEPVKPFLFY RAKTGRTSTL ESVAFPDWFI ASSKRDQPII LTSELGKSYN TAFELNIND |